A proposal of an echocardiography-based pathway for the diagnosis and management of angina with no obstructive coronary arteries: a state-of-the-art review: Advancing Targeted Therapy and Prognosis Through Endotype Identification

Eur Heart J Imaging Methods Pract. 2026 Jul 22;4(3):qyag129. doi: 10.1093/ehjimp/qyag129. eCollection 2026 Aug.ABSTRACTIn this paper we are discussing the currently available tools in the diagnosis of angina with non-occlusive coronary artery disease (ANOCA) a potentially disabling condition that af

A Attila Kardos

Sonographic Grading of Non-alcoholic Fatty Liver Disease and Its Association With Serum Biomarkers, Echocardiography, and Electrocardiogram

Cureus. 2026 Jul 8;18(7):e112256. doi: 10.7759/cureus.112256. eCollection 2026 Jul.ABSTRACTINTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is increasingly recognized as a systemic disorder associated with cardiovascular morbidity. Sonogr

C Channabasava Reddy

An interpretable machine learning model for predicting 1-year major adverse cardiovascular events in patients with type 2 diabetes and hypertension

Front Med (Lausanne). 2026 Jul 24;13:1871693. doi: 10.3389/fmed.2026.1871693. eCollection 2026.ABSTRACTBACKGROUND: Patients with coexisting type 2 diabetes mellitus (T2DM) and hypertension (HTN) face a synergistically elevated risk of major adverse cardiovascular events (MACE). Evidence for predicti

J Juan Lv

Risk of cardiovascular events in kidney transplant recipients undergoing PCI: a systematic review and meta-analysis

Br J Cardiol. 2026 May 5;33(2):023. doi: 10.5837/bjc.2026.023. eCollection 2026.ABSTRACTCardiovascular disease is a leading cause of mortality in patients with chronic kidney disease (CKD) and kidney transplant recipients (KTR). However, it remains uncertain whether KTR status predisposes patients t

I Isabella Ellison

Improving medication adherence in cardiovascular disease

Br J Cardiol. 2026 Apr 1;33(2):016. doi: 10.5837/bjc.2026.016. eCollection 2026.ABSTRACTThe management and prevention of cardiovascular diseases (CVD) is based on adequate adherence to medications and lifestyle changes. The reported rates of adherence with cardiovascular medications range from 30% t

H Hassan Al-Riyami

Real-world efficacy of inclisiran: data from a tertiary lipid clinic

Br J Cardiol. 2026 Apr 1;33(2):015. doi: 10.5837/bjc.2026.015. eCollection 2026.ABSTRACTSmall-interfering RNA (siRNA)-based therapies, such as inclisiran, offer a novel approach to reducing low-density lipoprotein-cholesterol (LDL-C) and preventing cardiovascular disease (CVD). Inclisiran inhibits p

M Matthew M A Waite

Functional genetic signatures of the gut microbiome in cardiometabolic diseases: mechanisms and translational opportunities

Front Microbiomes. 2026 Jul 24;5:1847345. doi: 10.3389/frmbi.2026.1847345. eCollection 2026.ABSTRACTThe human gut microbiome plays a very important role in the regulation of host metabolism and overall physiological homeostasis. Disruptions in microbial community function have been increasingly impl

M Martin Nganga Muigano

Health profiles and lifestyles of those with cardiomyopathy vs. age-matched controls: a UK Biobank analysis

Br J Cardiol. 2026 May 5;33(2):022. doi: 10.5837/bjc.2026.022. eCollection 2026.ABSTRACTCardiomyopathies are diseases of the heart muscle (ICD-10 chapter IX, code I42). This study compared the health profiles of individuals with cardiomyopathy to age- and sex-matched controls in the UK Biobank prosp

S Sherif Kholeif

Pre-Infection COVID-19 Vaccination and Long-Term Cardiovascular Outcomes in Adults Without Preexisting Cardiovascular Disease: A Retrospective Cohort Study

Health Sci Rep. 2026 Aug 6;9(8):e73014. doi: 10.1002/hsr2.73014. eCollection 2026 Aug.ABSTRACTBACKGROUND: Long-term cardiovascular complications after COVID-19 are increasingly recognized, yet the protective effect of pre-infection vaccination in individuals without prior cardiovascular disease (CVD

A Abdul Qadeer

Prevalence of Coronary Artery Diseases Among Adult Women Residents of Tehran: A Cross-Sectional Report From Tehran Cohort Study (TeCS)

Cardiol Res Pract. 2026 Aug 6;2026:1614045. doi: 10.1155/crp/1614045. eCollection 2026.ABSTRACTBACKGROUND: Coronary artery disease (CAD) is the leading cause of death worldwide. Among women, CAD is often underestimated, resulting in underdiagnosis and undertreatment. This study aimed to assess the p

A Amirhossein Heidari

Multigene panel analysis of connective tissue and vascular genes in patients with a bleeding disorder of unknown cause or a cerebrovascular event

Res Pract Thromb Haemost. 2026 Jul 10;10(5):106839. doi: 10.1016/j.rpth.2026.106839. eCollection 2026 Jul.ABSTRACTBACKGROUND: Bleeding disorder of unknown cause (BDUC) refers to patients with a significant bleeding phenotype despite normal hemostatic evaluation. Cerebrovascular events (CVEs) are neu

M Mona Florquin

Hearts in motion: Evaluating the utility of a mobile health unit in Ireland for cardiovascular disease prevention

Public Health Pract (Oxf). 2026 Jul 28;12:100835. doi: 10.1016/j.puhip.2026.100835. eCollection 2026 Dec.ABSTRACTOBJECTIVES: Hypertension is the leading cause of cardiovascular disease and premature death worldwide. This study evaluates the effectiveness of the Irish Heart Foundation's Mobile Health

N N Briggs

Two-Point Change Patterns of LDL-Cholesterol and hs-CRP and Risk of Major Adverse Cardiovascular Events in Middle-Aged and Older Chinese Adults: A Prospective Cohort Study

Health Sci Rep. 2026 Aug 6;9(8):e72842. doi: 10.1002/hsr2.72842. eCollection 2026 Aug.ABSTRACTBACKGROUND AND AIMS: The associations of two-point change patterns of low-density lipoprotein cholesterol (LDL-C) and high-sensitivity C-reactive protein (hs-CRP) with major adverse cardiovascular events (M

J Jiayin Guo

Biological clocks and blood clots in space: circadian disruption-induced modulation of thrombosis risk

Res Pract Thromb Haemost. 2026 Jul 14;10(5):106840. doi: 10.1016/j.rpth.2026.106840. eCollection 2026 Jul.ABSTRACTLong-duration space missions expose astronauts to microgravity, radiation, confinement, fluid redistribution, and circadian disruption, which together induce physiological adaptations, i

Z Zeinab Ibrahim

In vitro comparison of the effects of abelacimab, dalteparin, and apixaban on catheter-induced clotting and thrombin generation

Res Pract Thromb Haemost. 2026 Jul 13;10(5):106832. doi: 10.1016/j.rpth.2026.106832. eCollection 2026 Jul.ABSTRACTBACKGROUND: Abelacimab is a fully human monoclonal antibody that binds factor XI, blocking its activation and activity. It is being compared with apixaban and dalteparin in patients with

R Ruiqi Yin

Sex differences in vascular function among individuals with heart failure: a systematic review

Int J Cardiol Heart Vasc. 2026 Jul 28;65:101979. doi: 10.1016/j.ijcha.2026.101979. eCollection 2026 Aug.ABSTRACTHeart failure with preserved ejection fraction (HFpEF) is more prevalent in women, whereas heart failure with reduced ejection fraction (HFrEF) predominates in men. Despite these well-esta

S Sara Younas

Comparison of monthly bleeding rates after direct oral anticoagulant initiation for venous thromboembolism and atrial fibrillation

Res Pract Thromb Haemost. 2026 Jul 10;10(5):106825. doi: 10.1016/j.rpth.2026.106825. eCollection 2026 Jul.ABSTRACTBACKGROUND: Direct oral anticoagulants (DOACs) are commonly used for the treatment of atrial fibrillation (AF) and venous thromboembolism (VTE) but increase the risk of bleeding.OBJECTIV

D Dominic Awuah

Comparative Efficacy and Safety of Antihypertensive Strategies in Diabetic Kidney Disease: Protocol for an Update of a Systematic Review and Component Network Meta-Analysis

Health Sci Rep. 2026 Aug 6;9(8):e73020. doi: 10.1002/hsr2.73020. eCollection 2026 Aug.ABSTRACTBACKGROUND AND AIMS: Chronic kidney disease (CKD) is a significant global contributor to morbidity and mortality, with hypertension and diabetes mellitus remaining its primary causes. Effective antihyperten

J Jamie J Edwards

Platelets in systemic lupus erythematosus: from hemostatic allies to pathogenic drivers

Front Immunol. 2026 Jul 24;17:1778274. doi: 10.3389/fimmu.2026.1778274. eCollection 2026.ABSTRACTSystemic lupus erythematosus (SLE) is a multisystem autoimmune disease; hematologic involvement is common and strongly associated with prognosis. Platelets-the second most abundant cellular component of

Y Yanzuo Wu

Knowledge, Attitude, and Practices Regarding Metabolic Syndrome Among Ambulance Support Personnel

Cureus. 2026 Jul 7;18(7):e112241. doi: 10.7759/cureus.112241. eCollection 2026 Jul.ABSTRACTBackground Metabolic syndrome (MetS) is a clustering of interrelated physiological disturbances, including central adiposity, hypertension, dyslipidemia, insulin resistance, and impaired glucose regulation, th

J Jheel R Tripathi

Temporal validation of the electronic health record cancer-associated thrombosis model in patients with low bleeding risk

Res Pract Thromb Haemost. 2026 Jul 14;10(5):106830. doi: 10.1016/j.rpth.2026.106830. eCollection 2026 Jul.ABSTRACTBACKGROUND: The electronic health record cancer-associated thrombosis (EHR-CAT) model was derived to predict cancer-associated venous thromboembolism (VTE). Prior validations often relie

J Jennifer La

Five-year cardiovascular outcomes across hypertensive disorders of pregnancy subtypes: a propensity-matched analysis

Front Cardiovasc Med. 2026 Jul 24;13:1875409. doi: 10.3389/fcvm.2026.1875409. eCollection 2026.ABSTRACTBACKGROUND: Hypertensive disorders of pregnancy (HDP) are established risk factors for future cardiovascular disease, yet long-term cardiovascular risk across specific HDP subtypes remains incomple

L Laith Alhuneafat

The impact of digital health on hospitalization and mortality in heart failure patients in low- and middle-income countries: a systematic review and meta-analysis

Eur Heart J Digit Health. 2026 Jul 22;7(7):ztag117. doi: 10.1093/ehjdh/ztag117. eCollection 2026 Aug.ABSTRACTAIM: Heart disease is the leading cause of death worldwide, and the growing prevalence of heart failure (HF) is a key contributor. Digital health (dHealth) modalities including mobile applica

P Preston Nicely

Twenty-four-hour movement patterns relate with cardiometabolic health in adults with obesity

Sport Sci Health. 2026;22(3):300. doi: 10.1007/s11332-026-01863-x. Epub 2026 Aug 6.ABSTRACTAIM: Low moderate-to-vigorous physical activity (MVPA), high sedentary behavior (SB), and inadequate sleep are individually associated with type 2 diabetes (T2D) risk. However, the aggregate impact of these mo

K Kevin Y Gendi